Fig. 2
Rates of objective disease activity assessment and therapeutic drug monitoring (TDM) prior to dose escalation of biologic therapy. (N = 292; 77 with UC and 215 with CD)
Fig. 2 | BMC Gastroenterology
Rates of objective disease activity assessment and therapeutic drug monitoring (TDM) prior to dose escalation of biologic therapy. (N = 292; 77 with UC and 215 with CD)